efflux pump inhibitor (UoS/MGB)

N/A

Report date: 2025/01/26 19:05:49
NME

Base Information

Drug Nameefflux pump inhibitor (UoS/MGB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Strathclyde
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of StrathclydeMgb Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A